Lyka Labs Ltd
Company Profile
Business description
Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment which is pharmaceuticals. The Company has a presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.
Contact
30, Forjett Street, Near Bhatia Hospital
Ground floor, Spencer Building (Block B & C)
Grant Road (West)
MumbaiMH400036
INDT: +91 2266112200
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2027
Employees
499
Stocks News & Analysis
stocks
US utilities stocks keep rallying as investors bet on power demand growth
stocks
What did Morningstar subscribers buy and sell during March?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,165.10 | 41.30 | -0.45% |
| CAC 40 | 8,298.73 | 62.75 | 0.76% |
| DAX 40 | 24,032.60 | 290.16 | 1.22% |
| Dow JONES (US) | 48,399.36 | 181.11 | 0.38% |
| FTSE 100 | 10,595.85 | 12.89 | 0.12% |
| HKSE | 25,872.32 | 211.47 | 0.82% |
| NASDAQ | 23,381.10 | 197.36 | 0.85% |
| Nikkei 225 | 57,877.39 | 1,374.62 | 2.43% |
| NZX 50 Index | 13,017.26 | 2.92 | -0.02% |
| S&P 500 | 6,916.98 | 30.74 | 0.45% |
| S&P/ASX 200 | 8,970.80 | 43.20 | -0.48% |
| SSE Composite Index | 4,026.63 | 38.07 | 0.95% |